M

Michael E. Birnbaum

Ragon Institute of MGH, MIT and Harvard

ORCID: 0000-0002-2281-3518

Publishes on CAR-T cell therapy research, T-cell and B-cell Immunology, Immune Cell Function and Interaction. 144 papers and 5.1k citations.

PubIndex Score71Top 29% · seniorHow it's scored

144Publications

5.1kTotal Citations

First publication: 1970First senior author: 2003

CAR-T cell therapy research T-cell and B-cell Immunology Immune Cell Function and Interaction Immunotherapy and Immune Responses vaccines and immunoinformatics approaches

Top publicationsby citations

Human LilrB2 Is a β-Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer’s Model

Taeho Kim, Carla J. Shatz, Maja Djurišić et al.|Science|2013

Cited by 425

Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide

Max Jan, Benjamin L. Ebert, Alexander Tepper et al.|Science Translational Medicine|2021

Cited by 257

Pooled screening for CAR function identifies novel IL-13Rα2-targeted CARs for treatment of glioblastoma

Khloe S. Gordon, Michael E. Birnbaum|Journal for ImmunoTherapy of Cancer|2025

Cited by 9

CARPOOL: A library-based platform to rapidly identify next generation chimeric antigen receptors

Taeyoon Kyung, Michael E. Birnbaum|bioRxiv (Cold Spring Harbor Laboratory)|2021

Cited by 4

Exploiting the Zinc Finger Degrome Targeted By Lenalidomide to Engineer Reversible Off-Switch Degradable Chimeric Antigen Receptors

Max Jan, Benjamin L. Ebert, Ana P. Castaño et al.|Blood|2019

Cited by 0